Chinese Biopharmaceutical Association Holds 15th Annual Conference in
Rockville, MD, June 12 - 13
The Chinese Biopharmaceutical Association-USA (CBA) announced today that it is holding its
15th Annual Conference June 12 -13 in Maryland, US. The event will highlight current
breakthroughs, new opportunities and future challenges in biopharmaceutical development. It
will also develop a platform for communication and collaboration among biopharmaceutical
companies, CROs, research institutions and government agencies, as well as individual research
scientists, biopharmaceutical executives, entrepreneurs and venture capitalists.
Potomac, MD (PRWEB) May 21, 2010 -- The Chinese Biopharmaceutical Association-USA (CBA) announced
today that it is holding its 15th Annual Conference June 12 -13 in Maryland, US.
The event will highlight current breakthroughs, new opportunities and future challenges in biopharmaceutical
development. It will also develop a platform for communication and collaboration among biopharmaceutical
companies, CROs, research institutions and government agencies, as well as individual research scientists,
biopharmaceutical executives, entrepreneurs and venture capitalists.
With an anticipated attendance of more than 500, the conference offers a unique opportunity for those interested
in fostering collaborations.
“The goal of our annual conference is to provide a place for bio-life scientists and executives interested in
developing and establishing global networks and partnerships to meet, share needs and opportunities and develop
relationships that can grow into powerful collaborations across the border,” said Sujuan Ba, Ph.D., chairperson of
the conference and President-elect of the Chinese Biopharmaceutical Association – USA. “Many partnerships
have been built on the base of the relationships made from the networking and discussions during our past
conferences.”
More than 30 distinguished speakers will be present, including keynote speakers Dr. Eric Green, Director,
National Human Gen